Bone homeostasis depends on the interplay between bone resporption by osteoclasts and bone formation by osteoblasts. Any Imbalance of this tightly regulated process can cause diseases such as osteoporosis. Therefore, the knowledge about the factors that regulate communication between osteoclasts and osteoblasts are critical to bone cell biology. Osteoporosis is a progressive systemic skeletal disease characterized by low bone mass density and deterioration of bone tissue. Mature miRNAs are about 22 nucleotide long non coding RNA molecules that are involved in regulatory processes intracellularly. A number of scientific studies have revealed a comprehensive and evidential knowledge about miRNAs that affect the bone metabolism by influencing bone formation and resorption processes. In this short review we have summarized the regulatory role of some selective miRNAs in bone formation.
Introduction
MicroRNAs are a class of small non-coding RNA molecules (about 22-nucleotide long) that are involved in a wide range of physiological and pathological processes. It is evident in many recent studies that miRNAs affect bone metabolism by influencing bone formation and resorption processes. In the last few years, a number of promising studies suggested miRNAs as potential biomarkers for osteoporosis. A tightly regulated balance between bone resorption (mediated by osteoclasts) and bone formation (mediated by osteoblasts) ensure a normal bone remodeling process and ultimately a mature healthy bone. Proper balance is controlled by the coupling of bone formation to bone resorption, which involves a number of coordinated signaling mechanisms. Nonetheless, an imbalance between bone resorption and bone formation may occur under certain pathological conditions, which leads to abnormal bone remodeling and the development of bone disorders. [1] 
miRNAs as gene regulatory elements.
MiRNAs were first reported in 1993 by Lee et al. [2] Mature miRNAs are about 22 nucleotide long non coding RNA molecules that are involved in regulatory processes intracellularly, but were detected also in the circulation and other body fluids . [3] They are one of the most studied regulators of gene expression in both physiological and pathological conditions. [4] miRNAS and noncoding RNAs are considered epigenetic regulators along with DNA methylation and histone modifications that regulate gene transcription. [5, 6] Regulatory tasks are executed at post-transcriptional level by the binding of miRNAs to the 3' UTR (untranslated region) of the target RNA and modulating their target in two possible, ways depending on the degree of the complementarity between the miRNA and the target sequences within 3′ untranslated regions (UTRs) of mRNA.
While miRNAs that bind with their targeted mRNAs at 3′ UTRs with partial complementarity result repress gene expression post-transcriptionally at the level of translation, without degradation of mRNA. [11, 12] 
miRNAs AND OSTEOBLAST DIFFERENTIATION
Osteoblastic bone formation process occurs in different stages: osteoblast proliferation; Extracellular matrix(ECM) maturation; ECM mineralization; and osteoblast apoptosis. A number of key steps are involved in osteoblast maturation starting form mesenchymal stem cells differentiation to preosteoblasts that is regulated by a transcription factor Runx2; these then differentiated into osteoblasts, regulated by a combined regulatory mechanism of Runx2 and osteoblast-specific transcription factor (Osx). [13] Multiple signaling pathways play role in osteogenic differentiation including Wnt/-catenin, bone morphogenetic protein (BMP), JAK/STAT, and MAPK. [14, 15] In addition, regulatory genes like Runx2, osterix, SMADs, TCF/LEF, NFATc1, Twist1, and AP-1 take partto activates Smad protein family and Wnt signal. [16] This activated Wnt pathway successively activates frizzled related protein (FRP) and promotes the expression of specific genes that result in the proliferation of stem cells, preosteoblasts, increasing osteoblasts numbers, and the resistance to apoptosis of osteoblasts. [17] Many studies have reported that the expression of particular miRNAs in osteoblast differentiation appears unregulated or down regulated. miRNas regulate the osteolasteogenesis by directly or indirectly affecting the above mentioned pathways. Some miRNAS have positive effective on osteoblast and promote their differentiation such as miR-29b, miR-2861 and miR-3960, miR-378 are important examples that enhance the osteoblastic differentiation. Conversely, while some miRNAs negatively regulatethe osteoblast by Inhibiting Osteoblastic Differentiation. Some important examples of osteoblastic inhibitory miRNAS are miR-204/miR-211, miR-133 and miR-135 , miR-125b, miR-206. Table. 1 of shows the list of reported important miRNAS with their target genes/pathways, effect on osteoblasteogenesis and the reference study in detail. 
miRNAs and Osteoclsat
Multinucleated osteoclast primarily originate from mononuclear macrophages. The process comprises the complex interaction of different pathway and receptors andregulated by a variety of cytokines. Mononuclear cells are stimulated by a number of cyto-regulatory elements ,most importantly osteoclast differentiation factor (RANKL), macrophage colony stimulating factor (M-CSF) and other positive stimulating factor, that leads to differentiate into osteoclasts. [66] Although different miRNAS contribute in regulating osteoblast differentiation however their effects on osteoclastogenesis have been less studied as compared to osteoblast. In Table 02 some selected miRNAs are listed with their target proteins/pathways, effects and reference studies. [67] , [68] , [69] , [70] miR-29 CDC42, SRGAP2, NFIA, CD93,CALCR promotes [71] miR-31-5p RhoA promotes [72] hsa-miR-133a-3p CXCL11, CXCR3 and SLC39A1 Inhibit/promotes [73] hsa-miR-422a CBL, CD226,IGF1,
PAG1,TOB2
promotes [74] hsa-miR-148a-3p MAFB Promotes [75] , [76] miR-183-5p HO-1 Promotes [77] miR-214-3p Pten Promotes [52] , [78] , miR-223-3p NFIA, IKKα Inhibits/promotes [78] , [79] , [80] , [81] , [82] [83], [84] , [85] , [86] , miR-9718 PIAS3 promotes [87] miR-7b-5p DC-STAMP Inhibits [88] miR-26a-5p CTGF Inhibits [89] miR-124-3p NFATc1, RhoA, Rac1 Inhibits [90] miR-125a-5p TRAF6 Inhibits [91] miR-146a-5p TRAF6, Stat1 Inhibits [92] , [93] , [94] miR-218-5p p38MAPK-c-Fos-
NFATc1
Inhibits [95] miR-503-5p RANK Inhibits [96] miR-34a-5p Tgif2 Inhibits
[97]
Conclusion
Despite the limitation of unclear role of miRNAs in bone disorders there is substantial information about some specific miRNAs relative to bone metabolism now emerging and making their use as a new tool for the early diagnosis of osteoporosis. 
